Available to mentor
Kira Newman MD, PhD is a Clinical Assistant Professor at the University of Michigan. She specializes in caring for patients with inflammatory bowel disease and is a member of the Inflammatory Bowel Disease Program at the University of Michigan. Dr. Newman earned her Bachelor Degree in History at Yale University. She earned her Medical Degree and completed a PhD in Epidemiology at Emory University. She completed her Internal Medicine Residency at the University of Washington and Gastroenterology Fellowship at the University of Michigan. Dr. Newman conducts mechanistic microbiome research on the role of the microbiome in Clostridioides difficile infection among people with inflammatory bowel disease, for which she was the recipient of a 2023 Career Development Award from the American College of Gastroenterology. Her clinical research focuses on health outcomes and healthcare equity for sexual and gender minority/LGBTQIA+ people with digestive diseases.
-
MDEmory University School of Medicine, Atlanta, 2017
-
PhDEmory University, Atlanta, 2015
-
BAYale University, New Haven, 2010
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Vélez C, Newman KL, Paul S, Berli JU, Tangpricha V, Targownik LE. Gastroenterology, 2024 Mar; 166 (3): 369 - 375.e2.Journal ArticleApproaching Digestive Health Care in Transgender and Gender-Diverse Communities.
DOI:10.1053/j.gastro.2024.01.011 PMID: 38395524 -
Vélez C, Newman KL, Paul S, Berli JU, Tangpricha V, Targownik LE. Clin Gastroenterol Hepatol, 2024 Mar; 22 (3): 441 - 447.e2.Journal ArticleApproaching Digestive Health Care in Transgender and Gender-Diverse Communities.
DOI:10.1016/j.cgh.2023.12.001 PMID: 38395527 -
Condray CD, Newman KL, Chedid VG. Nat Rev Gastroenterol Hepatol, 2024 Sep 2;Journal ArticleConsequences of bathroom restriction on transgender individuals with gastrointestinal conditions in the United States.
DOI:10.1038/s41575-024-00975-4 PMID: 39223340 -
Newman KL, Allegretti JR. Am J Gastroenterol, 2024 Jan 1; 119 (1S): S30 - S35.Journal ArticleEmerging Noninfectious Indications for Live Biotherapeutic Products in Gastroenterology.
DOI:10.14309/ajg.0000000000002584 PMID: 38153224 -
Noureldin M, Newman KL, Higgins PDR, Piette JD, Resnicow K, Louissaint J, Kenney B, Berinstein J, Waljee AK, Zhu J, Cohen-Mekelburg S. Inflamm Bowel Dis, 2024 Jan 5; 30 (1): 83 - 89.Journal ArticleProfiles of Web-based Portal Users with Inflammatory Bowel Disease.
DOI:10.1093/ibd/izad056 PMID: 37071851 -
Newman KL, Goldowsky A, Vélez C. Am J Gastroenterol, 2023 Dec 1; 118 (12): 2109 - 2111.Journal ArticleEngaging Sexual and Gender Minority Communities in Digestive Health Research.
DOI:10.14309/ajg.0000000000002333 PMID: 37216592 -
Newman KL, Higgins PDR. J Clin Microbiol, 2023 Dec 19; 61 (12): e0094623Journal ArticleFecal calprotectin level is nonlinearly associated with GI pathogen detection in patients with and without inflammatory bowel disease.
DOI:10.1128/jcm.00946-23 PMID: 38038481 -
Sheehan JL, Jordan AA, Newman KL, Johnson LA, Eloubeidi D, Cohen-Mekelburg S, Berinstein JA, Tipirneni R, Higgins PDR. Inflamm Bowel Dis, 2023 Oct 25;Journal ArticleAre Depression and Anxiety Underdiagnosed in Socially Vulnerable Patients With Inflammatory Bowel Disease?
DOI:10.1093/ibd/izad246 PMID: 37878586